Metraipolis › archive › dc_22d7c1ccf4e6

Histone Deacetylase Inhibitors (HDACis) as Latency-Reversing Agents in HIV Cure Strategies: Chemistry, Selectivity, and Clinical Perspective — Europe PMC PMID:42357682

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42357682
DOI
10.3390/v18060673
License (as archived)
solo-consultazione
Archived
2026-10-19T09:25:02.669Z
SHA-256 of the archived text
2d81f8b6a9f65cc02f3948ad49b8f969c93c2c764f9f407e6a206a7c5b246f93
Stable URL of this page
https://metraipolis.com/documento/dc_22d7c1ccf4e6

How to cite

Histone Deacetylase Inhibitors (HDACis) as Latency-Reversing Agents in HIV Cure Strategies: Chemistry, Selectivity, and Clinical Perspective — Europe PMC PMID:42357682 — Europe PMC (en), https://europepmc.org/article/MED/42357682 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_22d7c1ccf4e6 (Metraipolis archive dc_22d7c1ccf4e6, sha256 2d81f8b6a9f65cc02f3948ad49b8f969c93c2c764f9f407e6a206a7c5b246f93)
BibTeX
@misc{dc22d7c1ccf4e6,
  title = {Histone Deacetylase Inhibitors (HDACis) as Latency-Reversing Agents in HIV Cure Strategies: Chemistry, Selectivity, and Clinical Perspective — Europe PMC PMID:42357682},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42357682},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_22d7c1ccf4e6; sha256 2d81f8b6a9f65cc02f3948ad49b8f969c93c2c764f9f407e6a206a7c5b246f93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357682. Agents can read the archived copy with the MCP tool read_document.